Consucon 30 MR

Presentation: Each modified-release (MR) tablet contains 30 mg of gliclazide. Consucon 30 MR tablets are typically white, oblong-shaped, and designed to release the medication gradually over an extended period. They are available in blister packs.

Indications: Consucon 30 MR is indicated for the management of type 2 diabetes mellitus in adults when diet, exercise, and weight reduction alone are not adequate to control blood glucose levels.

Dosage and Administration: The usual starting dose is one tablet (30 mg) once daily, taken orally at breakfast. The dosage may be adjusted gradually based on blood glucose response, usually in increments of 30 mg at intervals of at least 2 weeks, up to a maximum of 120 mg once daily. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed. Dosage should be individualized by the physician based on the patient's needs. Regular blood glucose monitoring is necessary to guide dosage adjustments.

Side Effects: The most common side effect is hypoglycemia (low blood sugar), which can manifest as sweating, dizziness, tremor, anxiety, increased heart rate, and confusion. Other possible side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Less common side effects may include headache,weight gain, and allergic skin reactions.

Precautions: Consucon 30 MR is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, severe renal or hepatic impairment, and known hypersensitivity to gliclazide or other sulfonylureas or sulfonamides. Caution should be exercised in patients with moderate renal or hepatic impairment, elderly patients, and those with risk factors for hypoglycemia (e.g., malnutrition, irregular meals, strenuous exercise, alcohol consumption, concomitant use of other hypoglycemic agents). Regular blood glucose monitoring is necessary. Alcohol consumption should be avoided as it can increase the risk of hypoglycemia. Certain medications may interact with gliclazide, affecting blood glucose control.

Storage: Store below 30°C in a dry place, protected from light. Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.